NYSE:RAD - Rite Aid Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $9.02 -0.11 (-1.20 %) (As of 05/20/2019 04:00 PM ET)Previous Close$9.13Today's Range$8.70 - $9.1552-Week Range$7.36 - $42.40Volume1.24 million shsAverage Volume1.10 million shsMarket Capitalization$486.19 millionP/E RatioN/ADividend YieldN/ABeta1.68 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services comprising screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order, specialty and compounding pharmacy, and infertility treatment services, as well as drug benefits under the federal government's Medicare Part D program. As of April 12, 2018, the company operated approximately 2,548 stores in 19 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania. Receive RAD News and Ratings via Email Sign-up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Drug stores & proprietary stores Sub-IndustryDrug Retail SectorRetail/Wholesale Current SymbolNYSE:RAD Previous Symbol CUSIP76775410 CIK84129 Webwww.riteaid.com Phone717-761-2633Debt Debt-to-Equity Ratio2.93 Current Ratio1.68 Quick Ratio0.91Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$21.64 billion Price / Sales0.02 Cash Flow$13.2647 per share Price / Cash Flow0.68 Book Value$21.98 per share Price / Book0.41Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-422,210,000.00 Net Margins-1.95% Return on Equity-1.21% Return on Assets-0.22%Miscellaneous Employees51,000 Outstanding Shares53,901,000Market Cap$486.19 million Next Earnings Date6/26/2019 (Estimated) OptionableOptionable Rite Aid (NYSE:RAD) Frequently Asked Questions What is Rite Aid's stock symbol? Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD." When did Rite Aid's stock split? How did Rite Aid's stock split work? Rite Aid shares reverse split on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split. How were Rite Aid's earnings last quarter? Rite Aid Co. (NYSE:RAD) released its quarterly earnings data on Thursday, April, 11th. The company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.60) by $0.40. The firm had revenue of $5.38 billion for the quarter, compared to analysts' expectations of $5.56 billion. Rite Aid had a negative return on equity of 1.21% and a negative net margin of 1.95%. During the same period in the previous year, the firm earned ($0.20) EPS. View Rite Aid's Earnings History. When is Rite Aid's next earnings date? Rite Aid is scheduled to release their next quarterly earnings announcement on Wednesday, June 26th 2019. View Earnings Estimates for Rite Aid. What guidance has Rite Aid issued on next quarter's earnings? Rite Aid updated its FY 2020 earnings guidance on Thursday, April, 11th. The company provided earnings per share guidance of $-0.01-0.04 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.02. The company issued revenue guidance of $21.5-21.9 billion, compared to the consensus revenue estimate of $22.09 billion. What price target have analysts set for RAD? 6 brokers have issued twelve-month price objectives for Rite Aid's shares. Their forecasts range from $20.00 to $120.00. On average, they anticipate Rite Aid's share price to reach $44.00 in the next year. This suggests a possible upside of 387.8% from the stock's current price. View Analyst Price Targets for Rite Aid. What is the consensus analysts' recommendation for Rite Aid? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 2 sell ratings and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Rite Aid. Has Rite Aid been receiving favorable news coverage? News coverage about RAD stock has been trending somewhat negative this week, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Rite Aid earned a news impact score of -1.6 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an impact on the company's share price in the near term. Are investors shorting Rite Aid? Rite Aid saw a increase in short interest in the month of April. As of April 15th, there was short interest totalling 207,551,625 shares, an increase of 23.0% from the March 29th total of 168,738,575 shares. Based on an average trading volume of 27,227,426 shares, the days-to-cover ratio is presently 7.6 days. Approximately 390.9% of the company's stock are sold short. View Rite Aid's Current Options Chain. Who are some of Rite Aid's key competitors? Some companies that are related to Rite Aid include 111 (YI), Petmed Express (PETS), Diplomat Pharmacy (DPLO), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP). What other stocks do shareholders of Rite Aid own? Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), Celgene (CELG), Akorn (AKRX), Bank of America (BAC), Cleveland-Cliffs (clf), Advanced Micro Devices (AMD), General Electric (ge), Mr. Cooper Group (COOP), Lantronix (LTRX) and AK Steel (aks). Who are Rite Aid's key executives? Rite Aid's management team includes the folowing people: Mr. John T. Standley, CEO & Director (Age 56)Mr. Kermit Ray Crawford, Pres & COO (Age 60)Mr. Bryan B. Everett, Chief Operating Officer (Age 46)Mr. Darren Wayne Karst, Exec. Officer (Age 59)Ms. Jocelyn Zazyczny Konrad, Exec. VP of Pharmacy & Retail Operations (Age 49) Who are Rite Aid's major shareholders? Rite Aid's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (138.27%), OppenheimerFunds Inc. (92.76%), JPMorgan Chase & Co. (46.77%), Geode Capital Management LLC (22.70%), Northern Trust Corp (22.55%) and Charles Schwab Investment Management Inc. (17.68%). View Institutional Ownership Trends for Rite Aid. Which major investors are selling Rite Aid stock? RAD stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, BlackRock Inc., California Public Employees Retirement System, Alpine Global Management LLC, Ladenburg Thalmann Financial Services Inc., Creative Planning, Northern Trust Corp and Parametric Portfolio Associates LLC. View Insider Buying and Selling for Rite Aid. Which major investors are buying Rite Aid stock? RAD stock was acquired by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Jacobs Levy Equity Management Inc., Charles Schwab Investment Management Inc., Geode Capital Management LLC, Connor Clark & Lunn Investment Management Ltd., Numen Capital LLP, Dupont Capital Management Corp and BNP Paribas Arbitrage SA. View Insider Buying and Selling for Rite Aid. How do I buy shares of Rite Aid? Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Rite Aid's stock price today? One share of RAD stock can currently be purchased for approximately $9.02. How big of a company is Rite Aid? Rite Aid has a market capitalization of $486.19 million and generates $21.64 billion in revenue each year. Rite Aid employs 51,000 workers across the globe. What is Rite Aid's official website? The official website for Rite Aid is http://www.riteaid.com. How can I contact Rite Aid? Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17011. The company can be reached via phone at 717-761-2633 or via email at [email protected] MarketBeat Community Rating for Rite Aid (NYSE RAD)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 597 (Vote Outperform)Underperform Votes: 596 (Vote Underperform)Total Votes: 1,193MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/20/2019 by MarketBeat.com StaffFeatured Article: Average Daily Trade Volume - What You Need to Know Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.